BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32050752)

  • 1. Oleoylethanolamide Exhibits GPR119-Dependent Inhibition of Osteoclast Function and GPR119-Independent Promotion of Osteoclast Apoptosis.
    Kim HJ; Lee DK; Jin X; Che X; Choi JY
    Mol Cells; 2020 Apr; 43(4):340-349. PubMed ID: 32050752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor 119 is involved in RANKL-induced osteoclast differentiation and fusion.
    Kim HJ; Yoon HJ; Park JW; Che X; Jin X; Choi JY
    J Cell Physiol; 2019 Jul; 234(7):11490-11499. PubMed ID: 30478996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-κB signaling and blocks cytoskeletal organization and survival in mature osteoclasts.
    Kim HJ; Yoon HJ; Kim SY; Yoon YR
    Mol Cells; 2014 Aug; 37(8):598-604. PubMed ID: 25134536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.
    Lauffer LM; Iakoubov R; Brubaker PL
    Diabetes; 2009 May; 58(5):1058-66. PubMed ID: 19208912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G Protein-Coupled Receptor 120 Signaling Negatively Regulates Osteoclast Differentiation, Survival, and Function.
    Kim HJ; Yoon HJ; Kim BK; Kang WY; Seong SJ; Lim MS; Kim SY; Yoon YR
    J Cell Physiol; 2016 Apr; 231(4):844-51. PubMed ID: 26280807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.
    Stone VM; Dhayal S; Smith DM; Lenaghan C; Brocklehurst KJ; Morgan NG
    Br J Pharmacol; 2012 Apr; 165(8):2758-70. PubMed ID: 22029844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPR119 Is a Potent Regulator of Human Sebocyte Biology.
    Markovics A; Angyal Á; Tóth KF; Ádám D; Pénzes Z; Magi J; Pór Á; Kovács I; Törőcsik D; Zouboulis CC; Bíró T; Oláh A
    J Invest Dermatol; 2020 Oct; 140(10):1909-1918.e8. PubMed ID: 32142797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells.
    Ning Y; O'Neill K; Lan H; Pang L; Shan LX; Hawes BE; Hedrick JA
    Br J Pharmacol; 2008 Dec; 155(7):1056-65. PubMed ID: 18724386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
    Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmatine attenuates osteoclast differentiation and function through inhibition of receptor activator of nuclear factor-κb ligand expression in osteoblast cells.
    Lee JW; Mase N; Yonezawa T; Seo HJ; Jeon WB; Cha BY; Nagai K; Woo JT
    Biol Pharm Bull; 2010; 33(10):1733-9. PubMed ID: 20930384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain.
    Suardíaz M; Estivill-Torrús G; Goicoechea C; Bilbao A; Rodríguez de Fonseca F
    Pain; 2007 Dec; 133(1-3):99-110. PubMed ID: 17449181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oea Signaling Pathways and the Metabolic Benefits of Vertical Sleeve Gastrectomy.
    Hutch CR; Trakimas DR; Roelofs K; Pressler J; Sorrell J; Cota D; Obici S; Sandoval DA
    Ann Surg; 2020 Mar; 271(3):509-518. PubMed ID: 30702457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of GPR119 receptor activity with endocannabinoid-like lipids.
    Syed SK; Bui HH; Beavers LS; Farb TB; Ficorilli J; Chesterfield AK; Kuo MS; Bokvist K; Barrett DG; Efanov AM
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1469-78. PubMed ID: 23074242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased signaling of lipids and allosteric actions of synthetic molecules for GPR119.
    Hassing HA; Fares S; Larsen O; Pad H; Hauge M; Jones RM; Schwartz TW; Hansen HS; Rosenkilde MM
    Biochem Pharmacol; 2016 Nov; 119():66-75. PubMed ID: 27569424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Osteoclast Differentiation at Multiple Stages by Protein Kinase D Family Kinases.
    Leightner AC; Mello Guimaraes Meyers C; Evans MD; Mansky KC; Gopalakrishnan R; Jensen ED
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.